Aspen stock stood at ZAc 15,670.00 with a 26.29 earnings multiple on October 16, 2026

Published on 10/17/2026 at 18:48 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

The earnings multiple was 26.29 on October 16, 2026. Aspen stock stood at ZAc 15,670.00 on October 16, 2026 at 5:00 p.m. SAST, up 0.08 percent on the JSE.

Valuation and dates

Aspen's earnings multiple stood at 26.29 on October 16, 2026.
Normalised EBITDA increased 10.00 percent to ZAR 7.7 billion in fiscal year 2026.
Aspen stock stood at ZAc 15,670.00 at 5:00 p.m. SAST on October 16, 2026, up 0.08 percent on the JSE.
Aspen's annual general meeting is scheduled for December 3, 2026.

Aspen, ZAE000066692, Illustration mit AI erstellt.

Aspen stock stood at ZAc 15,670.00 on the Johannesburg Stock Exchange on October 16, 2026 at 5:00 p.m. SAST, up 0.08 percent from the prior close. The valuation signal is a 26.29 earnings multiple, while the next shareholder date is December 3, 2026.

Valuation follows fiscal results

Aspen's latest reported fiscal year ended June 30, 2026. On its investor-relations page, Aspen Pharmacare said normalised EBITDA increased 10.00 percent to ZAR 7.7 billion. Normalised headline earnings per share also increased 10.00 percent, while free cash flow before dividends reached ZAR 3.8 billion.

The reported figures give the market a concrete earnings anchor after the fiscal 2026 results. Aspen also said Commercial Pharmaceuticals, its principal operating division, delivered 13.00 percent constant-currency EBITDA growth in fiscal year 2026. The business operates 23 manufacturing facilities across 15 sites, according to the same investor-relations page.

Price position and trading range

The October 16 close left Aspen at ZAc 951.00 below its 52-week high of ZAc 16,621.00 and ZAc 6,600.00 above its 52-week low of ZAc 9,070.00. That places the stock 5.72 percent below the high and 72.88 percent above the low. Trading volume was 544,788 shares against an average of 1,600,965 shares.

Valuation and shareholder dates

The market capitalization was ZAR 67.8 billion and the dividend yield was 1.00 percent on October 16, 2026. The price-to-earnings ratio of 26.29 gives the valuation paragraph a clear numerical reference.

A JSE filing dated October 2, 2026 listed Aspen's next annual general meeting for December 3, 2026. The record date is November 27, 2026, and the last day to trade for participation is November 24, 2026, according to Sharedata.

Comparison with peers

Aspen (JSE, ZAc): plus 0.08 percent, earnings multiple 26.29, market capitalization ZAR 67.8 billion.

Dis-Chem Pharmacies (JSE, ZAc): minus 2.23 percent, earnings multiple 23.87, market capitalization ZAR 23.3 billion.

Clicks Group (JSE, ZAc): minus 1.25 percent, earnings multiple 16.99, market capitalization ZAR 55.6 billion.

Market view stays number-led

Aspen's fiscal figures, valuation and shareholder calendar now define the stock's near-term market frame. The next observable date is the annual general meeting on December 3, 2026.

Aspen stock stood at ZAc 15,670.00 on October 16, 2026 at 5:00 p.m. SAST, up 0.08 percent on the JSE.